The Rapid Rise in Resistant Strains (Image Credits: Unsplash)
A recent report from the Centers for Disease Control and Prevention documents a sharp increase in extensively drug-resistant Shigella infections across the United States. The analysis examined more than 16,000 Shigella isolates collected from 2011 through 2023, revealing that cases resistant to multiple frontline antibiotics rose dramatically over the period.[1][2] Health officials emphasized the pathogen’s potential to spread through contaminated food and water, complicating efforts to control outbreaks.
The Rapid Rise in Resistant Strains
Extensively drug-resistant Shigella cases emerged as a significant concern starting in 2016, with no such isolates detected from 2011 to 2015. By 2023, these strains accounted for 8.5 percent of tested infections, up from zero a decade earlier.[1] The CDC identified 510 XDR isolates out of 16,788 with resistance data, and more than 84 percent of them surfaced in just the final two years of the study period.
This acceleration prompted heightened surveillance. Regional patterns showed concentrations in the West and Northeast, where certain serogroups dominated. Public health experts linked the trend to evolving resistance mechanisms that allow the bacteria to evade common treatments.
Key Characteristics of XDR Shigella
Shigella bacteria cause shigellosis, an illness marked by severe diarrhea, fever, and stomach cramps that typically lasts about a week. Extensively drug-resistant strains resist five critical antibiotics: ampicillin, azithromycin, ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole.[3] About two-thirds of XDR cases involved Shigella sonnei, the most common species in the U.S., while Shigella flexneri appeared at higher rates than in general surveillance.
Laboratory analysis through whole-genome sequencing and susceptibility testing confirmed the resistance profiles. An additional 33 percent of XDR isolates resisted chloramphenicol as well. No resistance appeared to meropenem or fosfomycin, though these remain limited options.
Who Faces the Highest Risks
Patients with XDR infections skewed toward adults, with a median age of 41 years and nearly 96 percent aged 18 or older. Men comprised 86 percent of cases with available data, alongside elevated rates of HIV co-infection at 47 percent among those tested.[1] Hospitalization occurred in 38 percent of documented instances, though no fatalities were reported.
Racial and ethnic breakdowns showed 75 percent White patients, with smaller proportions Black or African American and Hispanic or Latino. Travel history played a minor role, as most cases lacked recent domestic or international trips. Factors like housing instability and sexual transmission routes warranted further investigation but lacked complete data.
Transmission Pathways and Food Safety Concerns
Shigella spreads primarily through the fecal-oral route, often via contaminated food or water. Raw produce, deli salads, and other ready-to-eat items pose particular risks if handled improperly. Person-to-person contact, including during sexual activity, and poor sanitation also facilitate spread.[3][4]
Food service workers represent a key prevention focus. The low infectious dose – just 10 to 100 bacteria – amplifies the threat in settings with inadequate handwashing or hygiene. Outbreaks have historically tied to contaminated water sources and shared facilities.
- Wash hands thoroughly with soap after using the bathroom and before handling food.
- Avoid preparing food while ill with diarrhea.
- Cook meats thoroughly and refrigerate leftovers promptly.
- Disinfect surfaces that may contact raw foods.
- Practice safe water habits during travel, such as avoiding tap water.
Treatment Hurdles and Prevention Imperatives
No FDA-approved oral antibiotics exist for XDR Shigella, leaving intravenous options or unapproved alternatives like pivmecillinam. Clinicians must rely on susceptibility testing to guide care, often requiring hospitalization for severe dehydration. The CDC urged expanded testing and reporting to track the pathogen’s evolution.
Prevention remains the cornerstone. Enhanced surveillance, targeted interventions for at-risk groups, and public education on hygiene could curb further spread. State and local health departments contributed vital data to the report, underscoring collaborative efforts.[1]
Key Takeaways
- XDR Shigella rose from 0% of cases in 2011–2015 to 8.5% in 2023.
- 510 cases identified, mostly in adult men, with 38% hospitalized.
- Focus on handwashing and food safety to interrupt fecal-oral transmission.
As drug resistance complicates shigellosis management, vigilance in food handling and hygiene offers the strongest defense. The CDC’s findings call for sustained action to protect public health. What steps will you take to stay safe? Tell us in the comments.
